DCAL - Dishman Carbogen Amcis

Dishman Carbogen Amcis

DCAL · Pharma > Pharmaceuticals & Drugs · Chairman: Janmejay R Vyas · MD: Arpit J Vyas · Listing date: Sept. 22, 2017 · Employees: 929 · Ahmedabad · http://imdcal.com

Stock Price vs Company Growth

1.3%

5.4%

1.4%

18.6%

13.5%

8.8%

22.6%

all

6.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 207 1.3%

185

264

Company Overview

Sales

2,650 Cr

Growth: 6.6%

Profit after Tax

-112 Cr

Growth: -35.8%

Small Cap

3,249 Cr

P/S: 1.2x

Industry P/S: 2.8x

Fundamentals

Sales (Cr)	₹ 2,650
Growth	6.6%
EBITDA	14.3%
P/S	1.2x
Dividend	0.0%
P/E	-29.7x
Book Value	₹ 2.9
PEG Ratio	-4.4x
ROE	-241.3%
P/B	70.6x

Shareholding Pattern

Institutions

L And T Mutual Fund Trustee Ltd-L And T Flexicap Fund

2.9 %

Mukul Agrawal

2.55 %

Government Pension Fund Global

2.33 %

Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund

1.88 %

Hbm Healthcare Investment(Cayman) Ltd.

1.62 %

Promoters

Adimans Technologies Llp

59.32 %

Others

Increase Decrease No change

Company Profile Detailed

The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Belongs to (13 Indices) view more

Investors (53)

tata.bal...

icici.pr...

jhunjhun...

Followers (1)

varsha96